<p>根据公司在最近向证券交易委员会提交的 13F 文件，文艺复兴资本公司在 2023 年第四季度将其在 Astera Labs, Inc.（纳斯达克代码：ALAB - 免费报告）的持股比例提高了 381.0%。该机构投资者在此期间购买了额外的 90,516 股后，持有该公司 114,276 股股票。Astera Labs 占文艺复兴资本公司投资组合的约 9.9%，使其成为第二大持股。文艺复兴资本公司在最近的报告期末持有的 Astera Labs 的股份约占 0.07%，价值 15,136,000 美元。</p>
<ul>
<li>隐藏的宝石：揭示 2024 年最佳软件股票</li>
</ul>
<p>其他一些对冲基金最近也对该公司的持仓进行了调整。战略蓝图公司在第三季度将其在 Astera Labs 的持股提高了 3.6%。战略蓝图公司现在持有 5,684 股该公司的股票，价值 298,000 美元，此前在此期间又购买了 195 股。GAMMA 投资公司在第四季度将其在 Astera Labs 的股份提高了 78.3%。GAMMA 投资公司现在持有 510 股该公司的股票，价值 68,000 美元，此前又收购了 224 股。Geneos 财富管理公司在第四季度获得了 Astera Labs 的新头寸，价值约 36,000 美元。瑞银资产管理美国公司（UBS AM）作为瑞银资产管理的一个独立业务单位，在第三季度将其在 Astera Labs 的持股提高了 5.7%。瑞银资产管理美国公司现在持有 5,284 股该公司的股票，价值 277,000 美元，此前在上个季度又收购了 284 股。最后，ORG 财富合伙公司在第四季度获得了 Astera Labs 的新股份，价值约 42,000 美元。60.47% 的股票由机构投资者和对冲基金持有。</p>
<h2>Astera Labs 股价下跌 3.3%</h2>
<p>周二，ALAB 的股价开盘为 98.12 美元。该公司的 50 日移动平均线为 122.46 美元，200 日移动平均线为 80.36 美元。Astera Labs, Inc.的 12 个月低点为 36.22 美元，12 个月高点为 147.39 美元。</p>
<ul>
<li>3 只在第三季度业绩强劲且 2024 年指引乐观的顶级股票</li>
</ul>
<p>Astera Labs（纳斯达克代码：ALAB - 获取免费报告）最近于 11 月 4 日发布了季度财报。该公司报告本季度每股收益为 0.23 美元，超出分析师一致预期的 0.17 美元，超出幅度为 0.06 美元。该公司本季度的收入为 1.131 亿美元，而分析师预期为 9750 万美元。Astera Labs 的净利润率为负 30.69%，股本回报率为负 15.57%。与去年同期相比，Astera Labs 本季度的收入增长了 47.1%。平均而言，股票研究分析师预计 Astera Labs, Inc.在当前财政年度将发布-0.45 的每股收益。</p>
<h2>分析师评级变动</h2>
<p>一些研究公司最近对 ALAB 发表了评论。德意志银行将 Astera Labs 的目标价从 60.00 美元上调至 100.00 美元，并在 11 月 5 日的研究报告中给予该公司 “买入” 评级。Craig Hallum 将 Astera Labs 的目标价从 75.00 美元上调至 105.00 美元，并在 11 月 5 日的报告中给予该股票 “买入” 评级。摩根大通将 Astera Labs 的目标价从 70.00 美元上调至 110.00 美元，并在 11 月 5 日的研究报告中给予该公司 “增持” 评级。Northland 证券在 1 月 28 日的研究报告中将 Astera Labs 的评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 120.00 美元的目标价。最后，Needham &amp; Company LLC 在 10 月 9 日的报告中重申了 “买入” 评级，并对 Astera Labs 的股票设定了 65.00 美元的目标价。一位股票研究分析师对该股票给予了持有评级，十一位分析师给予了买入评级，一位分析师给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “买入”，共识目标价为 107.42 美元。</p>
<ul>
<li>Astera Labs 的股价大幅上涨：这种增长能否持续？</li>
</ul>
<p><strong>查看我们对 ALAB 的最新分析</strong></p>
<h2>内部人士买卖</h2>
<p>在其他 Astera Labs 的新闻中，董事 Manuel Alba 在 12 月 4 日的交易中出售了 11,000 股该公司的股票。该股票以 117.50 美元的平均价格出售，总交易额为 1,292,500.00 美元。交易后，该董事现在直接持有 456,863 股公司股票，价值约 53,681,402.50 美元。这笔交易代表其持股减少了 2.35%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。此外，内部人士 Sanjay Gajendra 在 11 月 7 日的交易中出售了 740,000 股 Astera Labs 的股票。该股票以 96.59 美元的平均价格出售，总交易额为 71,476,600.00 美元。交易后，该内部人士现在直接持有 775,000 股公司股票，价值 74,857,250 美元。这代表其持股减少了 48.84%。该出售的披露信息可在此处找到。内部人士在上个季度出售了价值 167,581,256 美元的 1,690,452 股公司股票。</p>
<h2>关于 Astera Labs</h2>
<p>（免费报告）</p>
<p>Astera Labs, Inc.设计、制造和销售基于半导体的云和人工智能基础设施连接解决方案。其智能连接平台由一系列数据、网络和内存连接产品组成，这些产品基于统一的软件定义架构，能够让客户大规模部署和运营高性能的云和人工智能基础设施。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，胜过 Astera Labs</li>
<li>高飞股票：2022 年 3 月的三只天然气股票</li>
<li>如何投资小盘股</li>
<li>TSX 风险交易所（前身为加拿大风险交易所）</li>
<li>这些是内部人士在一月份购买的分红股票</li>
<li>黄金交叉股票：模式、示例和图表</li>
<li>2025 年的 “无买入” 趋势如何推动这三只股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 Astera Labs 吗？</h2>
<p>在考虑 Astera Labs 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Astera Labs 并不在名单上。</p>
<p>虽然 Astera Labs 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ALAB

<p>Renaissance Capital LLC 在第四季度将其在 Astera Labs, Inc. (NASDAQ:ALAB) 的持股增加了 381%，在收购了 90,516 股后，持有 114,276 股。Astera Labs 占 Renaissance 投资组合的 9.9%，估值为 1510 万美元。其他对冲基金也调整了他们的持仓。Astera Labs 的股票开盘价为 98.12 美元，下跌 3.3%。该公司报告第三季度每股收益为 0.23 美元，超出预期。分析师提高了价格目标，普遍评级为 “买入”，平均目标为 107.42 美元</p>

<p>Renaissance Capital LLC boosted its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 381.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 114,276 shares of the company's stock after purchasing an additional 90,516 shares during the period. Astera Labs accounts for about 9.9% of Renaissance Capital LLC's portfolio, making the stock its 2nd biggest holding. Renaissance Capital LLC owned about 0.07% of Astera Labs worth $15,136,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>根据公司在最近向证券交易委员会提交的 13F 文件，文艺复兴资本公司在 2023 年第四季度将其在 Astera Labs, Inc.（纳斯达克代码：ALAB - 免费报告）的持股比例提高了 381.0%。该机构投资者在此期间购买了额外的 90,516 股后，持有该公司 114,276 股股票。Astera Labs 占文艺复兴资本公司投资组合的约 9.9%，使其成为第二大持股。文艺复兴资本公司在最近的报告期末持有的 Astera Labs 的股份约占 0.07%，价值 15,136,000 美元。</p>
</div><ul>
<li>Hidden Gems: Uncovering 2024's Best Software Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>隐藏的宝石：揭示 2024 年最佳软件股票</li>
</ul>
</div><p>A number of other hedge funds have also recently made changes to their positions in the company. Strategic Blueprint LLC lifted its holdings in Astera Labs by 3.6% during the 3rd quarter. Strategic Blueprint LLC now owns 5,684 shares of the company's stock worth $298,000 after buying an additional 195 shares during the period. GAMMA Investing LLC lifted its stake in shares of Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company's stock worth $68,000 after acquiring an additional 224 shares during the period. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs in the fourth quarter worth approximately $36,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Astera Labs by 5.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company's stock valued at $277,000 after acquiring an additional 284 shares during the last quarter. Finally, ORG Wealth Partners LLC acquired a new stake in Astera Labs during the 4th quarter valued at approximately $42,000. 60.47% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也对该公司的持仓进行了调整。战略蓝图公司在第三季度将其在 Astera Labs 的持股提高了 3.6%。战略蓝图公司现在持有 5,684 股该公司的股票，价值 298,000 美元，此前在此期间又购买了 195 股。GAMMA 投资公司在第四季度将其在 Astera Labs 的股份提高了 78.3%。GAMMA 投资公司现在持有 510 股该公司的股票，价值 68,000 美元，此前又收购了 224 股。Geneos 财富管理公司在第四季度获得了 Astera Labs 的新头寸，价值约 36,000 美元。瑞银资产管理美国公司（UBS AM）作为瑞银资产管理的一个独立业务单位，在第三季度将其在 Astera Labs 的持股提高了 5.7%。瑞银资产管理美国公司现在持有 5,284 股该公司的股票，价值 277,000 美元，此前在上个季度又收购了 284 股。最后，ORG 财富合伙公司在第四季度获得了 Astera Labs 的新股份，价值约 42,000 美元。60.47% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Astera Labs Trading Down 3.3 %</h2>
<div class="lb-trans"><h2>Astera Labs 股价下跌 3.3%</h2>
</div><p>Shares of ALAB opened at $98.12 on Tuesday. The business's fifty day moving average is $122.46 and its 200 day moving average is $80.36. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.</p>
<div class="lb-trans"><p>周二，ALAB 的股价开盘为 98.12 美元。该公司的 50 日移动平均线为 122.46 美元，200 日移动平均线为 80.36 美元。Astera Labs, Inc.的 12 个月低点为 36.22 美元，12 个月高点为 147.39 美元。</p>
</div><ul>
<li>3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只在第三季度业绩强劲且 2024 年指引乐观的顶级股票</li>
</ul>
</div><p>Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs's revenue for the quarter was up 47.1% compared to the same quarter last year. On average, equities research analysts expect that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Astera Labs（纳斯达克代码：ALAB - 获取免费报告）最近于 11 月 4 日发布了季度财报。该公司报告本季度每股收益为 0.23 美元，超出分析师一致预期的 0.17 美元，超出幅度为 0.06 美元。该公司本季度的收入为 1.131 亿美元，而分析师预期为 9750 万美元。Astera Labs 的净利润率为负 30.69%，股本回报率为负 15.57%。与去年同期相比，Astera Labs 本季度的收入增长了 47.1%。平均而言，股票研究分析师预计 Astera Labs, Inc.在当前财政年度将发布-0.45 的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of research firms have recently commented on ALAB. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Astera Labs from $60.00 to $100.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, November 5th. Craig Hallum increased their price target on Astera Labs from $75.00 to $105.00 and gave the stock a &#34;buy&#34; rating in a report on Tuesday, November 5th. JPMorgan Chase &amp; Co. boosted their price objective on Astera Labs from $70.00 to $110.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, November 5th. Northland Securities raised Astera Labs from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $120.00 target price for the company in a research note on Tuesday, January 28th. Finally, Needham &amp; Company LLC reiterated a &#34;buy&#34; rating and issued a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of &#34;Buy&#34; and a consensus price target of $107.42.</p>
<div class="lb-trans"><p>一些研究公司最近对 ALAB 发表了评论。德意志银行将 Astera Labs 的目标价从 60.00 美元上调至 100.00 美元，并在 11 月 5 日的研究报告中给予该公司 “买入” 评级。Craig Hallum 将 Astera Labs 的目标价从 75.00 美元上调至 105.00 美元，并在 11 月 5 日的报告中给予该股票 “买入” 评级。摩根大通将 Astera Labs 的目标价从 70.00 美元上调至 110.00 美元，并在 11 月 5 日的研究报告中给予该公司 “增持” 评级。Northland 证券在 1 月 28 日的研究报告中将 Astera Labs 的评级从 “市场表现” 上调至 “跑赢大盘”，并设定了 120.00 美元的目标价。最后，Needham &amp; Company LLC 在 10 月 9 日的报告中重申了 “买入” 评级，并对 Astera Labs 的股票设定了 65.00 美元的目标价。一位股票研究分析师对该股票给予了持有评级，十一位分析师给予了买入评级，一位分析师给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “买入”，共识目标价为 107.42 美元。</p>
</div><ul>
<li>Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?</li>
</ul>
<div class="lb-trans"><ul>
<li>Astera Labs 的股价大幅上涨：这种增长能否持续？</li>
</ul>
</div><p><strong>Check Out Our Latest Analysis on ALAB</strong></p>
<div class="lb-trans"><p><strong>查看我们对 ALAB 的最新分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人士买卖</h2>
</div><p>In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares in the company, valued at approximately $53,681,402.50. This trade represents a 2.35 % decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, insider Sanjay Gajendra sold 740,000 shares of Astera Labs stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $96.59, for a total transaction of $71,476,600.00. Following the transaction, the insider now directly owns 775,000 shares in the company, valued at $74,857,250. This represents a 48.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,690,452 shares of company stock worth $167,581,256 in the last quarter.</p>
<div class="lb-trans"><p>在其他 Astera Labs 的新闻中，董事 Manuel Alba 在 12 月 4 日的交易中出售了 11,000 股该公司的股票。该股票以 117.50 美元的平均价格出售，总交易额为 1,292,500.00 美元。交易后，该董事现在直接持有 456,863 股公司股票，价值约 53,681,402.50 美元。这笔交易代表其持股减少了 2.35%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站获取。此外，内部人士 Sanjay Gajendra 在 11 月 7 日的交易中出售了 740,000 股 Astera Labs 的股票。该股票以 96.59 美元的平均价格出售，总交易额为 71,476,600.00 美元。交易后，该内部人士现在直接持有 775,000 股公司股票，价值 74,857,250 美元。这代表其持股减少了 48.84%。该出售的披露信息可在此处找到。内部人士在上个季度出售了价值 167,581,256 美元的 1,690,452 股公司股票。</p>
</div><h2>About Astera Labs</h2>
<div class="lb-trans"><h2>关于 Astera Labs</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.</p>
<div class="lb-trans"><p>Astera Labs, Inc.设计、制造和销售基于半导体的云和人工智能基础设施连接解决方案。其智能连接平台由一系列数据、网络和内存连接产品组成，这些产品基于统一的软件定义架构，能够让客户大规模部署和运营高性能的云和人工智能基础设施。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Astera Labs</li>
<li>High Flyers: 3 Natural Gas Stocks for March 2022</li>
<li>How to Invest in Small Cap Stocks</li>
<li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li>
<li>These Are the Dividend Stocks Insiders Bought in January</li>
<li>Golden Cross Stocks: Pattern, Examples and Charts</li>
<li>How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Astera Labs</li>
<li>高飞股票：2022 年 3 月的三只天然气股票</li>
<li>如何投资小盘股</li>
<li>TSX 风险交易所（前身为加拿大风险交易所）</li>
<li>这些是内部人士在一月份购买的分红股票</li>
<li>黄金交叉股票：模式、示例和图表</li>
<li>2025 年的 “无买入” 趋势如何推动这三只股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxBQg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALAB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Astera Labs Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Astera Labs 吗？</h2>
</div><p>Before you consider Astera Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Astera Labs 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Astera Labs 并不在名单上。</p>
</div><p>While Astera Labs currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Astera Labs 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Renaissance Capital LLC 增加了其在 Astera Labs, Inc. (NASDAQ:ALAB) 的股票持有量